Skip to main content
Fig. 2 | Trials

Fig. 2

From: Abdominal Septic Shock – Endotoxin Adsorption Treatment (ASSET) – endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial

Fig. 2

Overall clinical investigational design. *Treatment with IMD or placebo device will be repeated on Day 2, i.e. 24 h after end of treatment on day 1.

§ Randomization will be performed as close as possible to start of treatment start (time-point O h) on Day 1

Back to article page